申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
公开号:US20040152725A1
公开(公告)日:2004-08-05
Disclosed are methods of treating certain cytokine mediated diseases or conditions using novel aromatic heterocyclic compounds of the formula(I) wherein Ar
1
, Ar
2
, L, Q and X are described herein.
1
本发明揭示了使用式(I)中所述的新芳香族杂环化合物治疗某些细胞因子介导的疾病或病况的方法,其中Ar1、Ar2、L、Q和X的定义如本文所述。